List I | List II | ||
A | Phase‐I | I | Post marketing surveillance |
B | Phase‐0 | II | Micro dosing |
C | Phase‐3 | III | First in human dose |
D | Phase‐4 | IV | Multicentric trials |
Choose the correct answer from the options given below:
Antibody | Description |
---|---|
P. IgE | (i) Cross the placenta |
Q. IgG | (ii) Dominant antibody produced in immune responses |
R. IgM | (iii) It is found in the mother's milk |
S. IgA | (iv) Responsible for autoimmune responses including allergies |